摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2-dimethyl-5-acetyl-1,3-benzoxathiole | 82255-58-1

中文名称
——
中文别名
——
英文名称
2,2-dimethyl-5-acetyl-1,3-benzoxathiole
英文别名
5-Acetyl-2,2-dimethyl-1,3-benzoxathiole;1-(2,2-Dimethyl-1,3-benzoxathiol-5-yl)ethanone
2,2-dimethyl-5-acetyl-1,3-benzoxathiole化学式
CAS
82255-58-1
化学式
C11H12O2S
mdl
——
分子量
208.281
InChiKey
VWYSFJIQRSRULY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    138-140 °C(Press: 3 Torr)
  • 密度:
    1.163±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    51.6
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] AMINE DERIVATIVES AS POTASSIUM CHANNEL BLOCKERS<br/>[FR] DÉRIVÉS D'AMINE AGISSANT COMME BLOQUEURS DU CANAL POTASSIUM
    申请人:BIONOMICS LTD
    公开号:WO2012155199A1
    公开(公告)日:2012-11-22
    The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.
    本发明涉及一种在细胞中调节钾通道活性的化合物,特别是发现在T细胞中的Kv1.3通道的活性。该发明还涉及利用这些化合物治疗或预防自身免疫和炎症性疾病,包括多发性硬化症,含有这些化合物的药物组合物以及其制备方法。
  • Amine derivatives
    申请人:Bionomics Limited
    公开号:EP2524912A1
    公开(公告)日:2012-11-21
    The present invention relates to Kv1.3 potassium channel blockers of Formula (I) and their use in the treatment of autoimmune and inflammatory diseases.
    本发明涉及公式(I)的Kv1.3钾通道阻滞剂及其在治疗自身免疫和炎症性疾病中的应用。
  • Amine Derivatives as Potassium Channel Blockers
    申请人:Harvey Andrew
    公开号:US20140336198A1
    公开(公告)日:2014-11-13
    The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.
    本发明涉及用于调节细胞中钾通道活性的化合物,特别是用于调节T细胞中发现的Kv1.3通道活性的化合物。本发明还涉及使用这些化合物治疗或预防自身免疫和炎症性疾病,包括多发性硬化症,含有这些化合物的制药组合物以及它们的制备方法。
  • Corda, Luciana; Fadda, Anna Maria; Maccioni, Antonio, Journal of Heterocyclic Chemistry, 1988, vol. 25, p. 311 - 314
    作者:Corda, Luciana、Fadda, Anna Maria、Maccioni, Antonio、Maccioni, Anna Maria、Podda, Gianni
    DOI:——
    日期:——
  • Bonsignore, Leonardo; Fadda, Anna Maria; Loy, Giuseppe, Journal of Heterocyclic Chemistry, 1984, vol. 21, p. 573 - 576
    作者:Bonsignore, Leonardo、Fadda, Anna Maria、Loy, Giuseppe、Maccioni, Anna Maria、Marongiu, Enrica、Podda, Gianni
    DOI:——
    日期:——
查看更多

同类化合物

四碘-2-磺基苯酸酐 四溴-2-磺基苯甲酸环酐 N,N'-二[[(1,3-苯并氧硫杂环戊烷-2-基)硫代]甲基]脲 5-羟基-4,6,7-三甲基-2-丙基-1,3-苯并氧杂噻唑 3-(5-羟基-4,6,7-三甲基-1,3-苯并氧杂噻唑-2-基)丙醇 2-磺基苯甲酸酐 2-(2-甲氧基丙烷-2-基)-7,7-二甲基-4-叔-丁基-8-氧杂-9-硫杂双环[4.3.0]壬-2,4,10-三烯 1,3-苯并噁噻唑,5-甲氧基-,3,3-二氧化 5,7-dimethyl-2-(2,2,2-trifluoro-1-methoxycarbonylethylidene)-1,3-benzooxathiole trans-6-fluoro-2',5-dimethoxy-6'-(trifluoromethyl)spiro[1,3-benzoxathiole-2,1'-cyclohex-2'-en]-4'-one 3,3-dioxide cis-6-fluoro-2',5-dimethoxy-6'-(trifluoromethyl)spiro[1,3-benzoxathiole-2,1'-cyclohex-2'-en]-4'-one 3,3-dioxide trans-2',5-dimethoxy-6'-methylspiro(1,3-benzoxathiole-2,1'-cyclohex-2'-en)-4'-one 3,3-dioxide cis-2',5-dimethoxy-6'-(trifluoromethyl)spiro[1,3-benzoxathiole-2,1'-cyclohex-2'-en]-4'-one 3,3-dioxide (2R,SS)-2-[(1S)-1-(4-methylphenyl)-1-(4-methoxyphenylamino)-methyl]-1,3-benzoxathiole 3(2H)-oxide 3,3-bis<(4-dimethylamino)phenyl>-4H-2,1-benzoxathiole 1-oxide 6-methyl-3,3-bis(4-dimethylaminophenyl)-3H-2,1-benzoxathiole 1-oxide (S)-6-(4-((R)-1-(5-ethylpyrimidin-2-yl)pyrrolidin-3-yl)methoxy-3-fluorophenyl)-2H-benzo[d][1,3]oxathiole 3-oxide 1,3-benzoxathiol-6-ol 1,3-benzoxathiol-6-ol-3-oxide 3,3-dioxido-2H-benzo[d][1,3]oxathiol-6-yl trifluoromethanesulfonate 5-(5-t-butyldimethylsilyloxy-4,6,7-trimethyl-1,3-benzoxathiole-2-yl)-2,2-dimethylpentanoic acid trans-6-fluoro-2',5-dimethoxy-6'-methylspiro(1,3-benzoxathiole-2,1'-cyclohex-2'-en)-4'-one 3,3-dioxide cis-6-fluoro-2',5-dimethoxy-6'-methylspiro(1,3-benzoxathiole-2,1'-cyclohex-2'-en)-4'-one 3,3-dioxide spiro<1,3-benzoxathiole-2,1'-cyclohexane> 3-oxide 4-Amino-3,3-dioxo-3λ6-benz[1,3]oxathiol-5-ol 6-Fluoro-1,3-benzoxathiol-2-amine 3H-2,1-Benzoxathiole 1,3-Benzoxathiole, 5-(1-(2-(2-ethoxyethoxy)ethoxy)ethoxy)- 4-[2-(4-Chloro-phenyl)-benzo[1,3]dithiol-2-yl]-2-[2-(4-chloro-phenyl)-benzo[1,3]oxathiol-2-yl]-1H-pyrrole 5-hydroxy-1,3-benzoxathiole 1,3-Benzoxathiole, 5-(1-(2-(4-chlorophenoxy)ethoxy)ethoxy)- 4-[2-(4-Methoxy-phenyl)-benzo[1,3]dithiol-2-yl]-2-[2-(4-methoxy-phenyl)-benzo[1,3]oxathiol-2-yl]-1H-pyrrole 5-hydroxy-2H-benzo[d][1,3]oxathiole 3,3-dioxide 4-(2-Methyl-benzo[1,3]dithiol-2-yl)-2-(2-methyl-benzo[1,3]oxathiol-2-yl)-1H-pyrrole 2,5-bis<2-(2-tert-butyl-1,3-benzoxathiolyl)>pyrrole 5-bromo-2-phenylbenzo[d][1,3]oxathiole 5-hydroxy-4,6,7-trimethyl-1,3-benzoxathiole 5-Ethoxy-1,1-dioxo-1H-1λ6-benzo[c][1,2]oxathiol-3-one 5-Butoxy-1,1-dioxo-1H-1λ6-benzo[c][1,2]oxathiol-3-one 2-t-Butyl-1,3-benzoxathiole 2-methyl-5'-nitrospiro(3H-2,1-benzoxathiole-1,1'-3H-1,2-benzisothiazole)-3(2H),3'-dione 2,5'-dimethylspiro(3H-2,1-benzoxathiole-1,1'-3H-1,2-benzisothiazole)-3(2H),3'-dione 3,3,3',3'-tetrakis(trifluoromethyl)-1,1'-spirobi<3H-2,1-benzoxathiole> 1-oxide 3-imino-3H-2,1-benzoxathiole-1,1-dioxide Bis-(2-carboxyphenyl)-Schwefel-dihydroxid-dilacton 6-tert-Butyl-1,1,2a,4,4-pentamethyl-2a,4-dihydro-1H-2,3-dioxa-2aλ4-thia-cyclopenta[cd]indene 2,2-dimethyl-6-oxo-8-phenyl-2H,6H-<1,2>thioxolo<4,5,1-hi>benzthioxole 2-(5-Tert-butyl-3,3-dimethyl-2,1-benzoxathiol-7-yl)propan-2-ol 9-tert-Butyl-2,2,4,6,6-pentamethyl-3,5-dioxa-4λ4-thia-tricyclo[5.3.1.04,11]undeca-1(10),7(11),8-triene 4-oxide 2-(5-tert-Butyl-1-chloro-1,3,3-trimethyl-1,3-dihydro-1λ4-benzo[c][1,2]oxathiol-7-yl)-propan-2-ol